The protective effect of rho-associated kinase inhibitor on aluminum-induced neurotoxicity in rat cortical neurons

Toxicological Sciences

Volumn 116, Issue 1, 2010, Pages 264-272

  Chen, Tsan Ju ^a   Hung, Hui Shan ^a   Wang, Dean Chuan ^a   Chen, Shun Sheng ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Aluminum; Amyloid ; Cultured cortical neurons; Rho ROCK

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALUMINUM MALTOL; AMYLOID; AMYLOID PRECURSOR PROTEIN; RHO KINASE; ALUMINUM; CULTURE MEDIUM; PROTEIN KINASE INHIBITOR;

ALUMINUM OVERLOAD; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN CORTEX; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; NERVE CELL; SPRAGUE DAWLEY RAT; TOXICITY;

ALUMINUM; ANIMALS; ANIMALS, NEWBORN; CEREBRAL CORTEX; CULTURE MEDIA, CONDITIONED; NEURONS; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES;

RATTUS;

EID: 77954366510     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq114     Document Type: Article

References (72)

1. Arimon, M., Díez-Pérez, I., Kogan, M. J., Durany, N., Giralt, E., Sanz, F., and Fernàndez-Busquets, X. (2005). Fine structure study of Abeta1-42 fibrillogenesis with atomic force microscopy. FASEB J. 19, 1344-1346.
2. Arispe, N., Rojas, E., and Pollard, H. B. (1993). Giant multilevel cation channels formed by Alzheimer disease amyloid β protein [AβP-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. U.S.A. 90, 10573-10577.
3. Avramovich, Y., Amit, T., and Youdim, M. B. (2002). Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein. J. Biol. Chem. 277, 31466-31473.
4. Bertholf, R. L., Herman, M. M., Savory, J., Carpenter, R. M., Sturgill, B. C., Katsetos, C. D., Vandenberg, S. R., and Wills, M. R. (1989). A long-term intravenous model of aluminum maltol toxicity in rabbits: tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure. Toxicol. Appl. Pharmacol. 98, 58-74.
5. Bhalla, P., and Dhawan, D. K. (2009). Protective role of lithium in ameliorating the aluminium-induced oxidative stress and histological changes in rat brain. Cell. Mol. Neurobiol. 29, 513-521.
6. Bharathi, Vasudevaraju, P., Govindaraju, M., Palanisamy, A. P., Sambamurti, K., and Rao, K. S. (2008). Molecular toxicity of aluminium in relation to neurodegeneration. Indian J. Med. Res. 128, 545-556.
7. Bjertness, E., Candy, J. M., Torvik, A., Ince, P., McArthur, F., Taylor, G. A., Johansen, S. W., Alexander, J., Grønnesby, J. K., Bakketeig, L. S., et al. (1996). Content of brain aluminum is not elevated in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 10, 171-174.
8. Bouras, C., Giannakopoulos, P., Good, P. F., Hsu, A., Hof, P. R., and Perl, D. P. (1997). A laser microprobe mass analysis of brain aluminum and iron in dementia pugilistica: comparison with Alzheimer's disease. Eur. Neurol. 38, 53-58.
9. Caccamo, A., Oddo, S., Sugarman, M. C., Akbarri, Y., and LaFerla, F. M. (2005). Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders. Neurobiol. Aging 26, 645-654.
10. Campbell, A., Kumar, A., La Rosa, F. G., Prasad, K. N., and Bondy, S. C. (2000). Aluminum increases levels of beta-amyloid and ubiquitin in neuroblastoma but not in glioma cells. Proc. Soc. Exp. Biol. Med. 223, 397-402.
11. Chen, T. J., Wang, D. C., and Chen, S. S. (2009). Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons. J. Neurosci. Res. 87, 2297-2307.
12. Crapper, D. R., Krishnan, S. S., and Dalton, A. J. (1973). Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180, 511-513.
13. Dewitt, D. A., Hurd, J. A., Fox, N., Townsend, B. E., GriYoen, K. J., Ghribi, O., and Savory, J. (2006). Peri-nuclear clustering of mitochondria is triggered during aluminium maltolate induced apoptosis. J. Alzheimer Dis. 9, 195-205.
14. Dong, J., Atwood, C. S., Anderson, V. E., Siedlak, S. L., Smith, M. A., Perry, G., and Carey, P. R. (2003). Metal binding and oxidation of amyloidbeta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry 42, 2768-2773.
15. Exley, C., Price, N. C., Kelly, S. M., and Birchall, J. D. (1993). An interaction of beta-amyloid with aluminium in vitro. FEBS Lett. 324, 293-295.
16. Flaten, T. P. (2001). Aluminum as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res. Bull. 55, 187-196.
17. Fu, H. J., Hu, Q. S., Lin, Z. N., Ren, T. L., Song, H., Cai, C. K., and Dong, S. Z. (2003). Aluminum-induced apoptosis in cultured cortical neurons and its effect on SAPK/JNK signal transduction pathway. Brain Res. 980, 11-23.
18. Furukawa, K., Abe, Y., and Akaike, N. (1994). Amyloid β protein-induced irreversible current in rat cortical neurons. Neuroreport 27, 2016-2018.
19. Gauthier, E., Fortier, I., Courchesne, F., Pepin, P., Mortimer, J., and Gauvreau, D. (2000). Aluminum forms in drinking water and risk of Alzheimer's disease. Environ. Res. 84, 234-246.
20. Glabe, C. G. (2004). Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem. Sci. 29, 542-547.
21. Harper, J. D., Wong, S. S., Lieber, C. M., and Lansbury, P. T. (1997). Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem. Biol. 4, 119-125.
22. Hironishi, M., Kordek, R., Yanagihara, R., and Garruto, R. M. (1996). Maltol (3-hydroxy-2-methyl-4-pyrone) toxicity in neuroblastoma cell lines and primary murine fetal hippocampal neuronal cultures. Neurodegeneration 5, 325-329.
23. Hirose, M., Ishizaki, T., Watanabe, N., Uehata, M., Kranenburg, O., Moolenaar, W. H., Matsumura, F., Maekawa, M., Bito, H., and Narumiya, S. (1998). Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J. Cell Biol. 141, 1625-1636.
24. House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., and Exley, C. (2004). Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease. J. Alzheimers Dis. 6, 291-301.
25. Irie, K., Murakami, K., Masuda, Y., Morimoto, A., Ohigashi, H., Ohashi, R., Takegoshi, K., Nagao, M., Shimizu, T., and Shirasawa, T. (2005). Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease. J. Biosci. Bioeng. 99, 437-447.
26. Ishizaki, T., Uehata, M., Tamechika, I., Keel, J., Nonomura, K., Maekawa, M., and Narumiya, S. (2000). Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol. Pharmacol. 57, 976-983.
27. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., and Ihara, Y. (1994). Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13, 45-53.
28. Jalink, K., Corven, E. V., Hengeveld, T., Morii, N., Narumiya, S., and Moolenaar, W. (1994). Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J. Cell Biol. 126, 801-810.
29. Johnson, V. J., Kim, S. H., and Sharma, R. P. (2005). Aluminum-maltolate induces apoptosis and necrosis in neuro-2a cells: potential role for p53 signaling. Toxicol. Sci. 83, 329-339.
30. Kaneko, N., Yasui, H., Takada, J., Suzuki, K., and Sakurai, H. (2004). Orally administrated aluminum-maltolate complex enhances oxidative stress in the organs of mice. J. Inorg. Biochem. 98, 2022-2031.
31. Kang, K. S., Kim, H. Y., Pyo, J. S., and Yokozawa, T. (2006). Increase in the free radical scavenging activity of ginseng by heat-processing. Biol. Pharm. Bull. 29, 750-754.
32. Kaur, A., Joshi, K., Walker, R. M., and Gill, K. D. (2006). Neurofilament phosphorylation and disruption: a possible mechanism of chronic aluminium toxicity in Wistar rats. Toxicology 219, 1-10.
33. Kawahara, M. (2004). Disruption of calcium homeostasis in Alzherimer's disease and other conformational disease. Curr. Alzheimer Res. 1, 87-95.
34. Kawahara, M. (2005). Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. J. Alzheimers Dis. 8, 171-182.
35. Kawahara, M., Kato, M., and Kuroda, Y. (2001). Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of b-amyloid protein. Brain Res. Bull. 55, 211-217.
36. Kawahara, M., Muramoto, K., Kobayashi, K., Mori, H., and Kuroda, Y. (1994). Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro. Biochem. Biophys. Res. Commun. 198, 531-535.
37. Kawahara, M., Negishi-Kato, M., and Sadakane, Y. (2009). Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein. Expert Rev. Neurother. 9, 681-693.
38. Kim, Y. B., Oh, S. H., Sok, D. E., and Kim, M. R. (2004). Neuroprotective effect of maltol against oxidative stress in brain of mice challenged with kainic acid. Nutr. Neurosci. 7, 33-39.
39. Konoha, K., Imamura, L., Tsuda, M., and Kawahara, M. (2003). Aluminum maltolate inhibits brain-derived neurotrophic factor induced intracellular free calcium elevations in cultured rat hippocampal neurons. Biomed. Res. Trace Elem. 14, 173-187.
40. Kubo, T., Yamaguchi, A., Iwata, N., and Yamashita, T. (2008). The therapeutic effects of Rho-ROCK inhibitors on CNS disorders. Ther. Clin. Risk Manag. 4, 605-615.
41. Kumar, V., Bal, A., and Gill, K. D. (2008). Impairment of mitochondrial energy metabolism in different regions of rat brain following chronic exposure to aluminium. Brain Res. 1232, 94-103.
42. Kuroda, Y., Kobayashi, K., Ichikawa, M., Kawahara, M., and Muramoto, K. (1995). Application of long-term cultured neurons in aging and neurological research: aluminum neurotoxicity, synaptic degeneration and Alzheimer's disease. Gerontology 41(Suppl. 1), 2-6.
43. Kushkuley,J.,Metkar,S.,Chan,W.K.,Lee,S.,andShea,T.B.(2010). Aluminum induces neurofilament aggregation by stabilizing cross-bridging of phosphorylated c-terminal sidearms. Brain Res. 1322, 118-123.
44. LaFerla, F. M., Green, K. N., and Oddo, S. (2007). Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 8, 499-509.
45. Landsberg, J. P., McDonald, B., and Watt, F. (1992). Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature 360, 65-68.
46. Langui, D., Probst, A., Anderton, B., Brion, J. P., and Ulrich, J. (1990). Aluminium-induced tangles in cultured rat neurones. Enhanced effect of aluminium by addition of maltol. Acta. Neuropathol. 80, 649-655.
47. LeVine, H., III. (1993). Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2, 404-410.
48. Ma, T., Zhao, Y., Kwak, Y. D., Yang, Z., Thompson, R., Luo, Z., Xu, H., and Liao, F. F. (2009). Statin's excitoprotection is mediated by sAPP and the subsequent attenuation of calpain-induced truncation events, likely via rho-ROCK signaling. J. Neurosci. 29, 11226-11236.
49. Martyn, C. N., Barker, D. J., Osmond, C., Harris, E. C., Edwardson, J. A., and Lacey, R. F. (1989). Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet 1, 59-62.
50. Matsui, T., Amano, M., Yamamoto, T., Chihara, K., Nakafuku, M., Ito, M., Nakano, T., Okawa, K., Iwamatsu, A., and Kaibuchi, K. (1996). Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 15, 2208-2216.
51. McDermott, J. R., Smith, A. I., Iqbal, K., and Wisniewski, H. M. (1979). Brain aluminum in aging and Alzheimer disease. Neurology 29, 809-814.
52. Mehta, P. D. (2007). Amyloid beta protein as a marker or risk factor of Alzheimer's disease. Curr. Alzheimer Res. 4, 359-363.
53. Meyer, G., and Feldman, E. L. (2002). Signaling mechanisms that regulate actin-based motility processes in the nervous system. J. Neurochem. 83, 490-503.
54. Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., and McConlogue, L. (2000). High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058.
55. Nostrandt, A. C., Shafer, T. J., Mundy, W. R., and Padilla, S. (1996). Inhibition of rat brain phosphatidylinositol-specific phospholipase C by aluminum: regional differences, interactions with aluminum salts, and mechanisms. Toxicol. Appl. Pharmacol. 136, 118-125.
56. Pedrini, S., Carter, T. L., Prendergast, G., Petanceska, S., Ehrlich, M. E., and Gandy, S. (2005). Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. PLoS Med. 2, e18.
57. Pike, C. J., Walenzcewicz, A. J., Glabe, C. G., and Cotman, C. W. (1991). In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563, 311-314.
58. Pratico, D., Uryu, K., Sung, S., Tang, S., Trojanowski, J. Q., and Lee, V. M. (2002). Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice. FASEB J. 16, 1138-1140.
59. Ricchelli, F., Drago, D., Filippi, B., Tognon, G., and Zatta, P. (2005). Aluminum-triggered structural modifications and aggregation of β-amyloids. Cell. Mol. Life Sci. 62, 1724-1733.
60. Savory, J., Herman, M. M., Hundley, J. C., Seward, R. L., Griggs, C. M., Katsetos, C. D., and Wills, M. R. (1993). Quantitative studies on aluminum deposition and its effects on neurofilament protein expression and phosphorylation, following the intraventricular administration of aluminum maltolate to adult rabbits. Neurotoxicology 14, 9-12.
61. Shcherbatykh, I., and Carpenter, D. O. (2007). The role of metals in the etiology of Alzheimer's disease. J. Alzheimers Dis. 11, 191-205.
62. Szekely, C. A., Thorne, J. E., Zandi, P. P., Ek, M., Messias, E., Breitner, J. C., and Goodman, S. N. (2004). Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 23, 159-169.
63. Takahashi, Y., Hayashi, I., Tominari, Y., Rikimaru, K., Morohashi, Y., Kan, T., Natsugari, H., Fukuyama, T., Tomita, T., and Iwatsubo, T. (2003). Sulindac sulfide is a noncompetitive gamma-secretase inhibitor that preferentially reduces Abeta 42 generation. J. Biol. Chem. 278, 18664-18670.
64. Thinakaran, G., and Koo, E. H. (2008). Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 283, 29615-29619.
65. van Ginkel, M. F., van der Voet, G. B., D'Haese, P. C., De Broe, M. E., and de Wolff, F. A. (1993). Effect of citric acid and maltol on the accumulation of aluminum in rat brain and bone. J. Lab. Clin. Med. 121, 453-460.
66. Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001). A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature 414, 212-216.
67. Weggen, S., Eriksen, J. L., Sagi, S. A., Pietrzik, C. U., Ozols, V., Fauq, A., Golde, T. E., and Koo, E. H. (2003). Evidence that nonsteroidal antiinflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity. J. Biol. Chem. 278, 31831-31837.
68. Xu, N., Majidi, V., Markesbery, W. R., and Ehmann, W. D. (1992). Brain aluminum in Alzheimer's disease using an improved GFAAS method. Neurotoxicology 13, 735-743.
69. Yumoto, S., Kakimi, S., Ohsaki, A., and Ishikawa, A. (2009). Demonstration of aluminum in amyloid fibers in the cores of senile plaques in the brains of patients with Alzheimer's disease. J. Inorg. Biochem. 103, 1579-1584.
70. Zhang, Y., McLaughlin, R., Goodyear, C., and LeBlanc, A. (2002). Selective cytotoxicity of intracellular amyloid-β peptide 1-42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156, 519-529.
71. 42 by inhibiting Rho. Science 302, 1215-1217.
72. Zou, K., Kim, D., Kakio, A., Byun, K., Gong, J. S., Kim, J., Kim, M., Sawamura, N., Nishimoto, S., Matsuzaki, K., et al. (2003). Amyloid β-protein (Aβ) 1-40 protects neurons from damage induced by Aβ1-42 in culture and in the brain. J. Neurochem. 87, 609-619.